Lori Lyons-Williams insider trades

Open-market stock purchases and sales by Lori Lyons-Williams, Director at Contineum Therapeutics, Inc, from SEC Form 4 filings since Jan 9, 2017.

Recent trades

DateStockTradeValue
Jun 26, 2026CTNM Contineum Therapeutics, IncBought (not open market)—
Mar 3, 2026RAPT RAPT Therapeutics, IncSold (not open market)—
Mar 3, 2026RAPT RAPT Therapeutics, IncSold (not open market)$861K
Mar 3, 2026RAPT RAPT Therapeutics, IncSold (not open market)$116K
Mar 3, 2026RAPT RAPT Therapeutics, IncSold (not open market)$271K
Mar 3, 2026RAPT RAPT Therapeutics, IncSold (not open market)$169K
Mar 3, 2026RAPT RAPT Therapeutics, IncSold (not open market)$240K
Jan 30, 2026RAPT RAPT Therapeutics, IncBought (not open market)—

Companies traded

  • CTNM Contineum Therapeutics, Inc: other filings, last Jun 26, 2026
  • RAPT RAPT Therapeutics, Inc: other filings, last Mar 3, 2026
  • FPRX Five Prime Therapeutics, Inc: other filings, last Apr 16, 2021
  • DERM Dermira, Inc: other filings, last Feb 20, 2020

Get free alerts when Lori Lyons-Williams files a new trade →